We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-8.36%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$74.3B
AUM Growth
-$8.62B
(-10%)
Cap. Flow
-$532M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
52.32%
Holding
784
New
89
Increased
180
Reduced
401
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$556M |
| 2 |
NVIDIA
NVDA
|
+$117M |
| 3 |
Oracle
ORCL
|
+$104M |
| 4 |
Amazon
AMZN
|
+$79.8M |
| 5 |
Expedia Group
EXPE
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$161M |
| 2 |
Parker-Hannifin
PH
|
+$138M |
| 3 |
Cummins
CMI
|
+$94.8M |
| 4 |
Mettler-Toledo International
MTD
|
+$82.8M |
| 5 |
Home Depot
HD
|
+$77.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.44% |
| 2 | Communication Services | 20.45% |
| 3 | Consumer Discretionary | 17.53% |
| 4 | Healthcare | 11.66% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Knife River
KNF
$4.15B
| $17.9M | 0.02% |
218,864
-190,072
| -46% | -$15.3M |
|
252
StoneX
SNEX
$9.39B
| $17.6M | 0.02% |
326,631
+40,503
| +14% | +$2.05M |
|
253
Intapp
INTA
$2.47B
| $17.5M | 0.02% |
682,467
+681,108
| +50,118% | +$20.3M |
|
254
US Foods
USFD
$22.1B
| $17.4M | 0.02% |
188,683
+40,665
| +27% | +$3.6M |
|
255
Performance Food Group
PFGC
$18B
| $17.3M | 0.02% |
201,510
-5,203
| -3% | -$476K |
|
|
CON
256
Concentra Group Holdings
CON
$4.05B
| $17.2M | 0.02% |
803,895
-29,613
| -4% | -$659K |
|
257
Fortrea Holdings
FTRE
$1.8B
| $17.2M | 0.02% |
+1,822,769
| New | +$23.4M |
|
258
Blue Bird Corp
BLBD
$2.36B
| $17.1M | 0.02% |
301,552
-14,260
| -5% | -$769K |
|
|
NPKI
259
NPK International
NPKI
$1.05B
| $17.1M | 0.02% |
1,177,993
-109,037
| -8% | -$1.51M |
|
260
Progyny
PGNY
$2.47B
| $16.8M | 0.02% |
988,390
+212,810
| +27% | +$4.56M |
|
261
Onto Innovation
ONTO
$12.5B
| $16.6M | 0.02% |
+81,072
| New | +$16.6M |
|
262
Atmus Filtration Technologies
ATMU
$4.22B
| $16.6M | 0.02% |
292,366
-59,621
| -17% | -$3.52M |
|
263
Bruker
BRKR
$9.79B
| $16.5M | 0.02% |
456,773
+8,579
| +2% | +$359K |
|
264
Planet Fitness
PLNT
$4.43B
| $16.5M | 0.02% |
221,343
-5,614
| -2% | -$494K |
|
265
TransUnion
TRU
$15.4B
| $16.4M | 0.02% |
237,724
+71,831
| +43% | +$5.5M |
|
|
INVX
266
Innovex International
INVX
$1.85B
| $16.4M | 0.02% |
+671,309
| New | +$16.9M |
|
267
nVent Electric
NVT
$23.4B
| $16.3M | 0.02% |
138,129
-26,959
| -16% | -$3.06M |
|
268
BJs Wholesale Club
BJ
$12.6B
| $16.3M | 0.02% |
165,143
-4,229
| -2% | -$408K |
|
|
WBI
269
WaterBridge Infrastructure LLC
WBI
$1.55B
| $16.1M | 0.02% |
+600,602
| New | +$14.3M |
|
270
Ecovyst
ECVT
$1.32B
| $15.8M | 0.02% |
1,225,131
-43,319
| -3% | -$489K |
|
271
TriMas Corp
TRS
$1.36B
| $15.7M | 0.02% |
436,921
-15,441
| -3% | -$554K |
|
|
SGI
272
Somnigroup International
SGI
$14.1B
| $15.6M | 0.02% |
211,498
+39,854
| +23% | +$3.46M |
|
273
ESAB
ESAB
$5.32B
| $15.5M | 0.02% |
160,152
-4,147
| -3% | -$480K |
|
274
First American
FAF
$7.71B
| $15.3M | 0.02% |
253,602
-3,453
| -1% | -$221K |
|
275
National Vision
EYE
$1.79B
| $15.1M | 0.02% |
584,038
+302,571
| +107% | +$8.22M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2026 Portfolio in Review
As of Q1 2026, Loomis, Sayles & Company held 784 positions worth $74.3B, down 10% from $83B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Loomis, Sayles & Company's Q1 2026 filing shows 89 new, 180 increased, 401 reduced and 66 closed positions. Its largest new stake was PTC Therapeutics: 493,603 shares worth $33.6M. The largest sale was Illumina, an estimated $161M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Loomis, Sayles & Company's largest Q1 2026 buy was PTC Therapeutics: 493,603 shares worth $33.6M.
- Loomis, Sayles & Company added most to Booking.com in Q1 2026, an estimated $556M increase.
- Loomis, Sayles & Company's biggest Q1 2026 reduction was Illumina, cutting an estimated $161M.
- Loomis, Sayles & Company fully exited Wave Life Sciences in Q1 2026, selling an estimated $34.7M.
- Loomis, Sayles & Company's ten largest holdings make up 52% of its $74.3B portfolio in Q1 2026.
- Loomis, Sayles & Company opened 89 new positions and closed 66 in Q1 2026.
- Loomis, Sayles & Company's portfolio value fell 10% quarter-over-quarter to $74.3B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.